---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-26T10:33:18.903930'
end_time: '2025-12-26T10:40:02.192325'
duration_seconds: 403.29
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: CHRAC1
  gene_symbol: CHRAC1
  uniprot_accession: Q9NRG0
  protein_description: 'RecName: Full=Chromatin accessibility complex protein 1; Short=CHRAC-1;
    AltName: Full=Chromatin accessibility complex 15 kDa protein; Short=CHRAC-15;
    Short=HuCHRAC15; AltName: Full=DNA polymerase epsilon subunit p15;'
  gene_info: Name=CHRAC1; Synonyms=CHRAC15;
  organism_full: Homo sapiens (Human).
  protein_family: Not specified in UniProt
  protein_domains: CBFA_NFYB_domain. (IPR003958); Histone-fold. (IPR009072); Transcr_DNA_Rep_Reg.
    (IPR050568); CBFD_NFYB_HMF (PF00808)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 17
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9NRG0
- **Protein Description:** RecName: Full=Chromatin accessibility complex protein 1; Short=CHRAC-1; AltName: Full=Chromatin accessibility complex 15 kDa protein; Short=CHRAC-15; Short=HuCHRAC15; AltName: Full=DNA polymerase epsilon subunit p15;
- **Gene Information:** Name=CHRAC1; Synonyms=CHRAC15;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** CBFA_NFYB_domain. (IPR003958); Histone-fold. (IPR009072); Transcr_DNA_Rep_Reg. (IPR050568); CBFD_NFYB_HMF (PF00808)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "CHRAC1" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'CHRAC1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **CHRAC1** (gene ID: CHRAC1, UniProt: Q9NRG0) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9NRG0
- **Protein Description:** RecName: Full=Chromatin accessibility complex protein 1; Short=CHRAC-1; AltName: Full=Chromatin accessibility complex 15 kDa protein; Short=CHRAC-15; Short=HuCHRAC15; AltName: Full=DNA polymerase epsilon subunit p15;
- **Gene Information:** Name=CHRAC1; Synonyms=CHRAC15;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** CBFA_NFYB_domain. (IPR003958); Histone-fold. (IPR009072); Transcr_DNA_Rep_Reg. (IPR050568); CBFD_NFYB_HMF (PF00808)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "CHRAC1" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'CHRAC1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **CHRAC1** (gene ID: CHRAC1, UniProt: Q9NRG0) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research plan and verification
- Identity check: The target is Homo sapiens CHRAC1 (UniProt Q9NRG0), also known as CHRAC-15/CHRAC15 and frequently referred to as POLE4 in the literature. It is a small histone-fold protein that forms a histone-fold heterodimer with CHRAC17/POLE3. This heterodimer functions within human CHRAC/ACF ISWI chromatin-remodeling complexes together with SMARCA5 (SNF2H) and BAZ1A (ACF1). This matches the UniProt description, organism, and domain annotations (histone fold/CBFA_NFYB family) (brown2010atpdependentchromatinremodeling pages 92-97, hartlepp2006characterisationofchrac14 pages 116-119).

Key concepts and definitions
- CHRAC1 (CHRAC-15/POLE4): A human histone-fold protein that heterodimerizes with CHRAC17/POLE3. As a dimer, it acts as a histone analog/chaperone module in chromatin-associated complexes, particularly ISWI remodelers (CHRAC/ACF) (brown2010atpdependentchromatinremodeling pages 92-97).
- Histone-fold heterodimer (POLE3–POLE4): A conserved H2A–H2B–like pair that associates with ISWI remodelers and with the DNA polymerase epsilon complex (orthology-based evidence), supporting nucleosome sliding/spacing and replication-coupled histone handling (brown2010atpdependentchromatinremodeling pages 92-97, hartlepp2006characterisationofchrac14 pages 116-119, casari2022resectionofdna pages 213-217).
- CHRAC/ACF complexes: ISWI-family ATP-dependent chromatin remodeling assemblies consisting of SMARCA5 (SNF2H) and BAZ1A (ACF1); in CHRAC, the POLE3–POLE4 heterodimer (CHRAC17–CHRAC15) enhances ATP-dependent nucleosome sliding activity and contributes to nucleosome spacing (brown2010atpdependentchromatinremodeling pages 92-97, borner2017rolesofnucleosome pages 22-25, jain2015effectsofnucleosome pages 95-99).
- Domain context: CHRAC1 contains a histone-fold/CBFA_NFYB-like domain; partner BAZ1A contributes WAC/DDT and PHD/bromodomain modules for chromatin targeting, and the histone-fold heterodimer engages the ACF1 N-terminus (WAC motif) (hartlepp2006characterisationofchrac14 pages 116-119, borner2017rolesofnucleosome pages 22-25).

Recent developments and latest research (priority 2022–2024)
- 2024 human ISWI interactome context: Tissue-specific interaction partners of SMARCA5 emphasize that CHRAC/ACF are major ISWI complexes mediating nucleosome spacing, with BAZ1A guiding targeting and SMARCA5 providing ATPase activity; the complex is implicated in DNA repair contexts (no CHRAC1-specific proteomics, but directly relevant complex-level updates) (Arishaka 2024; publication type: study/dissertation; URL not available) (arishaka2024identificationofnew pages 17-21).
- 2022 Drosophila mechanistic links with centromere and stress: The histone-fold subunit CHRAC-14 (fly ortholog of human POLE3/POLE4 family) regulates CENP-A loading and gene expression, shows context-dependent associations with centromeric proteins and other remodelers under DNA damage, and interacts with Pol ε–related factors (Mes4), underscoring a conserved theme of CHRAC histone-fold dimers in centromere function and stress-responsive chromatin maintenance (Doppler 2022; https://doi.org/10.11588/heidok.00031436; Jan 2022) (doppler2022thehistonefold pages 20-23, doppler2022thehistonefold pages 73-75).
- 2022 synthesis on DSB resection and replication chaperoning: Review synthesizes that POLE3–POLE4 (Dbp3/Dbp4 orthologs) serve in replication-coupled histone handling and that ISWI remodelers contribute to DSB processing, situating CHRAC1’s histone-fold dimer within DNA replication and repair pathways (Casari 2022; review; URL not available) (casari2022resectionofdna pages 213-217).

Molecular function and biochemical roles
- Structural role: CHRAC1 functions as a histone-fold protein forming a stable heterodimer with CHRAC17/POLE3 that mimics H2A–H2B. This dimer enhances ISWI remodeling activities, particularly nucleosome sliding by SMARCA5–BAZ1A, and contributes to nucleosome spacing/assembly (brown2010atpdependentchromatinremodeling pages 92-97, borner2017rolesofnucleosome pages 22-25, jain2015effectsofnucleosome pages 95-99).
- Interaction with remodelers: The heterodimer engages ACF1’s N-terminus (WAC motif), supporting assembly and function of ACF/CHRAC complexes (hartlepp2006characterisationofchrac14 pages 116-119).
- Replication-associated chaperone function: Orthology-informed and review-based evidence indicates that the POLE3–POLE4 pair acts as a histone chaperone at replication forks for parental histone (H3–H4) redeposition; Drosophila and yeast lines of evidence place the histone-fold pair at the replication-coupled chromatin interface (casari2022resectionofdna pages 213-217, borner2017rolesofnucleosome pages 22-25).

Subcellular localization
- Nuclear: The CHRAC15/CHRAC17 (POLE4/POLE3) histone-fold dimer is imported to the nucleus as a heterodimer; ACF1/SNF2H accumulate at pericentric heterochromatin in late S-phase in referenced cell studies, consistent with nuclear chromatin roles (Brown 2010) (brown2010atpdependentchromatinremodeling pages 92-97).

Biological processes and pathways
- Chromatin remodeling and organization: CHRAC/ACF remodelers slide and space nucleosomes to promote chromatin assembly and establish a repressive ground state of chromatin; the CHRAC1-containing histone-fold dimer enhances these activities (borner2017rolesofnucleosome pages 22-25, jain2015effectsofnucleosome pages 95-99).
- DNA replication: The POLE3–POLE4 histone-fold chaperone pair supports replication-coupled parental histone handling and chromatin integrity; in human cells, CHRAC1 (POLE4) is the CHRAC component of this conserved module (casari2022resectionofdna pages 213-217, brown2010atpdependentchromatinremodeling pages 92-97).
- DNA damage response and repair: Evidence from Drosophila shows CHRAC histone-fold subunits contribute to DNA damage checkpoint integrity and repair efficiency; broader reviews link ISWI remodelers to DSB resection and processing, situating CHRAC1 at the interface of chromatin remodeling and repair (doppler2022thehistonefold pages 20-23, casari2022resectionofdna pages 213-217).
- Centromere/kinetochore regulation: Drosophila data indicate CHRAC-14 limits aberrant CENP-A loading and engages centromeric interactors; this suggests conserved centromeric chromatin maintenance roles for the histone-fold dimer family (doppler2022thehistonefold pages 20-23, doppler2022thehistonefold pages 73-75).

Current applications and real-world implementations
- Functional genomics and proteomics: Co-immunoprecipitation/mass spectrometry approaches identify CHRAC/ACF complex constituents and replication-linked associates (e.g., RFC subunits, Cdc6) in vivo, informing network models of replication-coupled chromatin maintenance where CHRAC1 participates (Jain 2015; https://doi.org/10.5282/edoc.19018; Jan 2015) (jain2015effectsofnucleosome pages 95-99).
- Chromatin and replication stress models: Cellular studies tracking ISWI/ACF1 localization during S phase and heterochromatin replication, and fly models of DNA damage/centromere regulation, are used to infer conserved roles of human CHRAC1 in chromatin robustness under replication stress (brown2010atpdependentchromatinremodeling pages 92-97, doppler2022thehistonefold pages 20-23).

Expert opinions and authoritative synthesis
- Mechanistic reviews emphasize that ISWI remodelers (including CHRAC/ACF) function in nucleosome spacing and repressive chromatin, and that POLE3–POLE4 serves a replication-coupled histone chaperone role; these syntheses provide consensus for CHRAC1’s placement in chromatin remodeling–replication interfaces (casari2022resectionofdna pages 213-217, borner2017rolesofnucleosome pages 22-25).

Relevant statistics and data points
- Nuclear import: CHRAC15–CHRAC17 imported as a heterodimer; ACF1/SNF2H colocalization at pericentric heterochromatin in late S phase (cell-based observations summarized in Brown 2010) (brown2010atpdependentchromatinremodeling pages 92-97).
- DNA damage phenotypes (fly): Depletion of CHRAC-14 causes hypersensitivity to genotoxic stress, failure of G2/M checkpoint, accumulation of γH2Av, and comet assay DNA damage, suggesting a conserved role in the DNA damage response; while quantitative values are not provided in the excerpt, the directionality is consistent and supported (Doppler 2022; Jan 2022) (doppler2022thehistonefold pages 20-23).

Open questions and limitations
- Direct, recent (2023–2024) human CHRAC1-specific mechanistic papers are limited in the present evidence set. Current understanding extrapolates from conserved complex biology, Drosophila/yeast orthologs, and reviews. Targeted human CHRAC1 studies defining its unique contributions beyond the POLE3–POLE4 dimer function remain an active area.

Source summary with URLs and dates
- Brown 2010. Atp-dependent chromatin remodeling complexes in Xenopus development. Summary includes human CHRAC composition and nuclear import; URL not available in excerpt (brown2010atpdependentchromatinremodeling pages 92-97).
- Doppler 2022. The histone fold protein CHRAC-14 controls CENP-A loading and gene expression in Drosophila melanogaster. Jan 2022. https://doi.org/10.11588/heidok.00031436 (doppler2022thehistonefold pages 20-23, doppler2022thehistonefold pages 73-75).
- Hartlepp 2006. Characterisation of CHRAC14 and CHRAC16… Jan 2006. https://doi.org/10.5282/edoc.5149 (hartlepp2006characterisationofchrac14 pages 116-119).
- Börner 2017. Roles of nucleosome remodeling factors ACF1 and Domino during Drosophila melanogaster oogenesis. Jan 2017. https://doi.org/10.5282/edoc.20348 (borner2017rolesofnucleosome pages 22-25).
- Jain 2015. Effects of nucleosome remodeling factor ACF1 on in vivo chromatin organization. Jan 2015. https://doi.org/10.5282/edoc.19018 (jain2015effectsofnucleosome pages 95-99).
- Casari 2022. Resection of DNA double-strand breaks: novel regulatory mechanisms by checkpoint proteins and chromatin remodelers. 2022. URL not available in excerpt (casari2022resectionofdna pages 213-217).
- Arishaka 2024. Identification of new tissue-specific interaction partners of chromatin remodelling ATPase Smarca5. 2024. URL not available in excerpt (arishaka2024identificationofnew pages 17-21).

Embedded evidence table
| Reference (first author, year) | Focus / Model | What it shows about CHRAC1/POLE4 or CHRAC complexes (one-sentence) | Key partners / complexes mentioned | URL (DOI or link) | Publication date (month/year) |
|---|---|---|---|---:|---:|
| Brown 2010 (brown2010atpdependentchromatinremodeling pages 92-97) | Review / Xenopus / comparative (human context discussed) | Describes CHRAC15/POLE4 as a histone-fold subunit of human HuCHRAC that forms a heterodimer with CHRAC17/POLE3, enhancing ISWI (ACF/SNF2H) nucleosome-sliding activity and imported to the nucleus as a dimer. | SNF2H (SMARCA5), ACF1 (BAZ1A), CHRAC17 (POLE3) | N/A | 2010 |
| Doppler 2022 (doppler2022thehistonefold pages 20-23) | Experimental thesis / Drosophila | Shows histone-fold CHRAC subunits (CHRAC-14) heterodimerize (with CHRAC-16), control CENP-A loading, influence gene expression, and connect to Pol ε-related factors under stress. | CHRAC-16, Mes4 (Pol ε link), CENP-A, ATRX, pBAF | https://doi.org/10.11588/heidok.00031436 | Jan/2022 |
| Doppler 2022 (doppler2022thehistonefold pages 73-75) | Experimental thesis / Drosophila (additional data) | Provides mass-spec evidence of context-dependent associations of CHRAC histone-fold subunits with centromeric proteins and other remodelers, and notes detection/antibody challenges. | CENP-A, DEK, XNP/ATRX, pBAF | https://doi.org/10.11588/heidok.00031436 | Jan/2022 |
| Arishaka 2024 (arishaka2024identificationofnew pages 17-21) | Proteomics / human tissues (SMARCA5 interactome) | Identifies tissue-specific interaction partners of SMARCA5 and emphasizes ISWI complexes (including CHRAC/ACF) in nucleosome spacing, chromatin targeting and DNA repair. | SMARCA5 (ISWI), BAZ1A (ACF1), other ISWI partners | N/A | 2024 |
| Casari 2022 (casari2022resectionofdna pages 213-217) | Review / mechanistic (multi-organism synthesis) | Summarizes conservation of CHRAC-family histone-fold subunits and links POLE3–POLE4 (Dbp3/Dbp4 orthologs) to roles in replication-coupled histone handling and DSB processing via remodeler interplay. | POLE3, POLE4, ISWI family remodelers | N/A | 2022 |
| Hartlepp 2006 (hartlepp2006characterisationofchrac14 pages 116-119) | Dissertation / molecular characterization (Drosophila focus) | Characterises CHRAC histone-fold subunits, reports structural/functional similarity between CHRAC and Pol ε histone-fold dimers, and shows interaction with ACF1 N-terminal WAC motif. | ACF1 (WAC motif), CHRAC16, Pol ε (shared subunit context) | https://doi.org/10.5282/edoc.5149 | Jan/2006 |
| Börner 2017 (borner2017rolesofnucleosome pages 22-25) | Dissertation / Drosophila oogenesis | Demonstrates ACF/CHRAC (ISWI complexes) use small histone-fold proteins as DNA chaperones for nucleosome sliding/spacing and parental histone redeposition, implicating roles at replication and chromatin assembly. | ACF1, ISWI, NAP-1 (cooperation in assembly) | https://doi.org/10.5282/edoc.20348 | Jan/2017 |
| Jain 2015 (jain2015effectsofnucleosome pages 95-99) | Proteomics / Drosophila in vivo studies | Proteomics shows stable ACF1 association with small CHRAC subunits and recovery of replication-associated proteins (RFCs, Cdc6), supporting functional links between CHRAC/ACF and replication-linked chromatin organization. | ACF1, ISWI, RFC3/RFC4, Cdc6 | https://doi.org/10.5282/edoc.19018 | Jan/2015 |


*Table: Concise, sourced summary of key experimental and review evidence (2006–2024) describing CHRAC1/CHRAC‑15 (POLE4) identity, conserved histone‑fold heterodimerization, complex memberships, and roles in nucleosome sliding, replication‑linked histone handling and DNA repair (context IDs cited).*

Conclusions
- CHRAC1 is the human histone-fold protein CHRAC-15/POLE4 that dimerizes with CHRAC17/POLE3, integrates into CHRAC/ACF ISWI chromatin remodeling complexes with SMARCA5 and BAZ1A, and localizes to the nucleus. This histone-fold dimer enhances nucleosome sliding/spacing, supports replication-coupled parental histone redeposition, and participates in chromatin maintenance under DNA damage and at centromeric chromatin. Current 2022–2024 sources reinforce these roles at the complex level and via orthology, while direct 2023–2024 human CHRAC1-specific mechanistic insights remain comparatively scarce and warrant further targeted investigation (brown2010atpdependentchromatinremodeling pages 92-97, doppler2022thehistonefold pages 20-23, hartlepp2006characterisationofchrac14 pages 116-119, borner2017rolesofnucleosome pages 22-25, jain2015effectsofnucleosome pages 95-99, casari2022resectionofdna pages 213-217, arishaka2024identificationofnew pages 17-21).

References

1. (brown2010atpdependentchromatinremodeling pages 92-97): EE Brown. Atp-dependent chromatin remodeling complexes in xenopus development. Unknown journal, 2010.

2. (hartlepp2006characterisationofchrac14 pages 116-119): Klaus F. Hartlepp. Characterisation of chrac14 and chrac16, the two histone fold subunits of the chromatin accessibility complex. Dissertation, Jan 2006. URL: https://doi.org/10.5282/edoc.5149, doi:10.5282/edoc.5149. This article has 0 citations.

3. (casari2022resectionofdna pages 213-217): E Casari. Resection of dna double-strand breaks: novel regulatory mechanisms by checkpoint proteins and chromatin remodelers. Unknown journal, 2022.

4. (borner2017rolesofnucleosome pages 22-25): Kenneth Börner. Roles of nucleosome remodeling factors acf1 and domino during drosophila melanogaster oogenesis. Dissertation, Jan 2017. URL: https://doi.org/10.5282/edoc.20348, doi:10.5282/edoc.20348. This article has 0 citations.

5. (jain2015effectsofnucleosome pages 95-99): Dhawal Jain. Effects of nucleosome remodeling factor acf1 on in vivo chromatin organization. Dissertation, Jan 2015. URL: https://doi.org/10.5282/edoc.19018, doi:10.5282/edoc.19018. This article has 1 citations.

6. (arishaka2024identificationofnew pages 17-21): Y Arishaka. Identification of new tissue-specific interaction partners of chromatin remodelling atpase smarca5. Unknown journal, 2024.

7. (doppler2022thehistonefold pages 20-23): Sarah Doppler. The histone fold protein chrac-14 controls cenp-a loading and gene expression in drosophila melanogaster. Text, Jan 2022. URL: https://doi.org/10.11588/heidok.00031436, doi:10.11588/heidok.00031436. This article has 0 citations and is from a peer-reviewed journal.

8. (doppler2022thehistonefold pages 73-75): Sarah Doppler. The histone fold protein chrac-14 controls cenp-a loading and gene expression in drosophila melanogaster. Text, Jan 2022. URL: https://doi.org/10.11588/heidok.00031436, doi:10.11588/heidok.00031436. This article has 0 citations and is from a peer-reviewed journal.

## Citations

1. brown2010atpdependentchromatinremodeling pages 92-97
2. arishaka2024identificationofnew pages 17-21
3. casari2022resectionofdna pages 213-217
4. jain2015effectsofnucleosome pages 95-99
5. doppler2022thehistonefold pages 20-23
6. borner2017rolesofnucleosome pages 22-25
7. doppler2022thehistonefold pages 73-75
8. https://doi.org/10.11588/heidok.00031436;
9. https://doi.org/10.5282/edoc.19018;
10. https://doi.org/10.11588/heidok.00031436
11. https://doi.org/10.5282/edoc.5149
12. https://doi.org/10.5282/edoc.20348
13. https://doi.org/10.5282/edoc.19018
14. https://doi.org/10.5282/edoc.5149,
15. https://doi.org/10.5282/edoc.20348,
16. https://doi.org/10.5282/edoc.19018,
17. https://doi.org/10.11588/heidok.00031436,